Looking Beyond Benefit-Cost Analysis to Measure the Value of Lifesaving Drugs
Close to 9 million people in India suffer from hepatitis C. If left untreated, the virus leads to cirrhosis or liver damage, which eventually causes death from organ failure or cancer.